REGENXBIO Inc - Company Profile

Powered by

All the sales intelligence you need on REGENXBIO Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how REGENXBIO Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with REGENXBIO Inc.

Back to companies

REGENXBIO Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on REGENXBIO Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into REGENXBIO Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Kenneth T. Mills

Chairman Executive Board Since: 2024 Age: 51

Mr. Kenneth T. Mills has been the Chairman of the company since 2024. Prior to this, he served as the President and Chief Executive Officer of the company from 2009-2024. Previously, he served as the Chief Financial Officer and the Vice President of Business Development at Meso Scale Diagnostics. Mr. Mills also served as the Director of Business Development for IGEN International.

Read Hide full bio of Kenneth T. Mills

Curran M. Simpson

Chief Executive Officer; Director; President Executive Board Since: 2024 Age: 64

Mr. Curran M. Simpson has been the Chief Executive Officer, Director, and President of the company since 2024. Prior to this, he served as the Chief Operations and Technology Officer of the company. Previously, he served as the Head of North American Supply Chain, Interim Chief Operating Officer, and Integration Lead at the Human Genome Sciences division of GlaxoSmithKline. Mr. Simpson also served as the Senior Vice President of Operations and Vice President of Manufacturing Operations at Human Genome Sciences; the Director of Manufacturing Sciences at Biogen; and Director of Engineering at Covance Biotechnology Services.

Read Hide full bio of Curran M. Simpson

Mitchell Chan

Chief Financial Officer; Executive Vice President; Treasurer Senior Management Since: 2024 Age: 45

Mr. Mitchell Chan has been the Executive Vice President, Chief Financial Officer, and Treasurer of the company since 2024. Prior to that, he served as the Operating Partner at Catalio Capital Management. Previously, he served as the Chief Financial Officer of Viela Bio, Inc.

Read Hide full bio of Mitchell Chan

Craig Malzahn

Chief Technology Officer; Executive Vice President - Product Development Senior Management Since: 2025 Age: 53

Mr. Craig Malzahn has been the Executive Vice President of Product Development and Chief Technology Officer of the company since 2025. Prior to this, he served as the Vice President and Site Head for GlaxoSmithKline plc. Previously, he served as the the Director, BioPharmaceutical Technology at GSK from April 2016 to December 2016 and the Director, Supply Chain at GSK from 2012 to 2017.

Read Hide full bio of Craig Malzahn

Patrick J. Christmas II

Chief Legal Officer Senior Management Age: 55

Mr. Patrick J. Christmas II is the Chief Legal Officer of the company. Prior to this, he served as the Vice President, General Counsel and Secretary at Lumara Health (formerly KV Pharmaceutical Co); General Counsel and Secretary at the Wellstat Group of Companies; and General Counsel at BioVeris Corporation. He has also worked at Akin, Gump.

Read Hide full bio of Patrick J. Christmas II
Gain a 360-degree view of REGENXBIO Inc and make more informed decisions for your business Gain a 360-degree view of REGENXBIO Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer